NDAQ:TRIP - Post Discussion
Post by
Axell1818 on Nov 02, 2020 5:24am
Compass Pathways
There is, however, an uphill battle for the recreational market. Michael Auerbach of Subversive Capital, an early investor in Compass Pathways, sees no robust path for psychedelics. “There is less of a diversified recreational market for psychedelics as there is for cannabis as it is used in a massive swath of consumer products,” Auerbach tells Observer.
Be the first to comment on this post